BIOXYTRAN, INC
BIXT · OTCMCIK 1445815fmd_0EFSQSZMD63J1H5GF9ATPGCZZ5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2026, 66 periods
Latest annual · FY2025
Millions- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q2 FY2026
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
BIOXYTRAN, INC (BIXT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.8 million | -$2.2 million | 10-K 2026-04-15 · proof | |
| Net income | -$2.1 million | -$2.4 million | 10-K 2026-04-15 · proof | |
| Cash from operating activities | -$526,455 | -$381,316 | 10-K 2026-04-15 · proof | |
| Total assets | $658,552 | 10-K 2026-04-15 · proof | ||
| Total liabilities | $3.2 million | 10-K 2026-04-15 · proof | ||
| Cash and cash equivalents | $509,914 | 10-K 2026-04-15 · proof |
- What was BIOXYTRAN, INC (BIXT)'s operating income in fiscal 2025?
- BIOXYTRAN, INC (BIXT) reported operating income of -$1.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOXYTRAN, INC (BIXT)'s net income in fiscal 2025?
- BIOXYTRAN, INC (BIXT) reported net income of -$2.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOXYTRAN, INC (BIXT)'s cash from operating activities in fiscal 2025?
- BIOXYTRAN, INC (BIXT) reported cash from operating activities of -$526,455 for fiscal 2025 (the year ended Dec 31, 2025), against -$381,316 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOXYTRAN, INC (BIXT)'s total assets?
- As of Dec 31, 2025, BIOXYTRAN, INC (BIXT) reported total assets of $658,552. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOXYTRAN, INC (BIXT)'s total liabilities?
- As of Dec 31, 2025, BIOXYTRAN, INC (BIXT) reported total liabilities of $3.2 million. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOXYTRAN, INC (BIXT)'s cash and cash equivalents?
- As of Dec 31, 2025, BIOXYTRAN, INC (BIXT) reported cash and cash equivalents of $509,914. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BIXT&period_type=annual&limit=5"Information only, not investment advice.